•
Feb 28
Neogen Q3 2025 Earnings Report
Neogen reported third-quarter results that reflected a decline in revenue and net income, impacted by macroeconomic uncertainty and lower sample collection sales.
Key Takeaways
Neogen posted a net loss of $11 million in Q3 2025 as revenue declined to $221 million. The company saw modest core growth in its Food Safety segment, but faced headwinds from sample collection issues and global trade uncertainty.
Total revenue was $221 million, down 3.4% from the prior year.
Adjusted EPS came in at $0.10 despite a reported net loss of $11 million.
Food Safety core revenue grew 1.5% with strength in biosecurity and sanitation products.
Neogen updated its full-year guidance due to macro uncertainty and expected Q4 tariff impact.
Neogen
Neogen
Neogen Revenue by Segment
Forward Guidance
Neogen revised its FY25 outlook downward due to Q3 performance, economic uncertainty, and anticipated tariffs in Q4.
Positive Outlook
- Solid core growth in the Food Safety segment
- Strong performance in pathogen detection and biosecurity products
- Progress in Petrifilm production ramp-up
- Improvements in sample collection production
- Resilient demand in historically stable food safety end-markets
Challenges Ahead
- Macroeconomic uncertainty dampening distributor confidence
- Decline in sample collection sales
- Foreign currency impacts reducing reported revenue
- Reduced Adjusted EBITDA margin
- Expected Q4 impact from new tariff regulations
Revenue & Expenses
Visualization of income flow from segment revenue to net income